Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing 100191, China.
National Clinical Research Center for Obstetrics and Gynecology, Beijing 100191, China.
Chin Med J (Engl). 2021 Sep 21;134(19):2306-2315. doi: 10.1097/CM9.0000000000001731.
Existing clinical prediction models for in vitro fertilization are based on the fresh oocyte cycle, and there is no prediction model to evaluate the probability of successful thawing of cryopreserved mature oocytes. This research aims to identify and study the characteristics of pre-oocyte-retrieval patients that can affect the pregnancy outcomes of emergency oocyte freeze-thaw cycles.
Data were collected from the Reproductive Center, Peking University Third Hospital of China. Multivariable logistic regression model was used to derive the nomogram. Nomogram model performance was assessed by examining the discrimination and calibration in the development and validation cohorts. Discriminatory ability was assessed using the area under the receiver operating characteristic curve (AUC), and calibration was assessed using the Hosmer-Lemeshow goodness-of-fit test and calibration plots.
The predictors in the model of "no transferable embryo cycles" are female age (odds ratio [OR] = 1.099, 95% confidence interval [CI] = 1.003-1.205, P = 0.0440), duration of infertility (OR = 1.140, 95% CI = 1.018-1.276, P = 0.0240), basal follicle-stimulating hormone (FSH) level (OR = 1.205, 95% CI = 1.051-1.382, P = 0.0084), basal estradiol (E2) level (OR = 1.006, 95% CI = 1.001-1.010, P = 0.0120), and sperm from microdissection testicular sperm extraction (MESA) (OR = 7.741, 95% CI = 2.905-20.632, P < 0.0010). Upon assessing predictive ability, the AUC for the "no transferable embryo cycles" model was 0.799 (95% CI: 0.722-0.875, P < 0.0010). The Hosmer-Lemeshow test (P = 0.7210) and calibration curve showed good calibration for the prediction of no transferable embryo cycles. The predictors in the cumulative live birth were the number of follicles on the day of human chorionic gonadotropin (hCG) administration (OR = 1.088, 95% CI = 1.030-1.149, P = 0.0020) and endometriosis (OR = 0.172, 95% CI = 0.035-0.853, P = 0.0310). The AUC for the "cumulative live birth" model was 0.724 (95% CI: 0.647-0.801, P < 0.0010). The Hosmer-Lemeshow test (P = 0.5620) and calibration curve showed good calibration for the prediction of cumulative live birth.
The predictors in the final multivariate logistic regression models found to be significantly associated with poor pregnancy outcomes were increasing female age, duration of infertility, high basal FSH and E2 level, endometriosis, sperm from MESA, and low number of follicles with a diameter >10 mm on the day of hCG administration.
现有的体外受精临床预测模型是基于新鲜卵母细胞周期的,尚无预测模型来评估冷冻成熟卵母细胞解冻成功的概率。本研究旨在识别和研究与急诊卵母细胞冻融周期妊娠结局相关的预取卵患者的特征。
数据来自中国北京大学第三医院生殖中心。使用多变量逻辑回归模型得出列线图。通过在开发和验证队列中检查判别和校准来评估列线图模型的性能。使用接收者操作特征曲线下的面积(AUC)评估判别能力,并使用 Hosmer-Lemeshow 拟合优度检验和校准图评估校准。
“无可转移胚胎周期”模型中的预测因素为女性年龄(比值比[OR] = 1.099,95%置信区间[CI] = 1.003-1.205,P = 0.0440)、不孕持续时间(OR = 1.140,95%CI = 1.018-1.276,P = 0.0240)、基础卵泡刺激素(FSH)水平(OR = 1.205,95%CI = 1.051-1.382,P = 0.0084)、基础雌二醇(E2)水平(OR = 1.006,95%CI = 1.001-1.010,P = 0.0120)和微切割睾丸精子提取(MESA)精子(OR = 7.741,95%CI = 2.905-20.632,P < 0.0010)。在评估预测能力时,“无可转移胚胎周期”模型的 AUC 为 0.799(95%CI:0.722-0.875,P < 0.0010)。Hosmer-Lemeshow 检验(P = 0.7210)和校准曲线显示,该模型对无可转移胚胎周期的预测具有良好的校准。累积活产的预测因素为人绒毛膜促性腺激素(hCG)给药日的卵泡数(OR = 1.088,95%CI = 1.030-1.149,P = 0.0020)和子宫内膜异位症(OR = 0.172,95%CI = 0.035-0.853,P = 0.0310)。“累积活产”模型的 AUC 为 0.724(95%CI:0.647-0.801,P < 0.0010)。Hosmer-Lemeshow 检验(P = 0.5620)和校准曲线显示,该模型对累积活产的预测具有良好的校准。
在最终的多元逻辑回归模型中发现与妊娠结局不良显著相关的预测因素是女性年龄增加、不孕持续时间延长、基础 FSH 和 E2 水平升高、子宫内膜异位症、MESA 精子和 hCG 给药日直径 >10mm 的卵泡数量减少。